Role of CAR-T Therapy in R/R Follicular Lymphoma

Opinion
Video

An overview of the evolving role of CAR-T therapy in patients with relapsed or refractory follicular lymphoma.

Related Videos
The approval for epcoritamab in patients with R/R follicular lymphoma was supported by encouraging efficacy findings from the phase 1/2 EPCORE NHL-1 trial.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
This series features 2 KOLs.
This series features 2 KOLs.
4 KOLs are featured in this panel.
4 KOLs are featured in this panel.
relapsed or refractory mantle cell lymphoma, glofitamab, Obinutuzumab, phase 1/2 study, NCT03075696, Tycel J. Phillips, MD
A panel of 4 experts on multiple myeloma
Related Content